Table 4 Details of Irinotecan DC/LC Bead Treatment.

N of treatments = 99

Total # of patients = 55

One treatment

55(100%)

Two treatments

28 (50%)

Three treatments

12(9%)

≥Four treatments

4(5%)

Maximum number of treatment sessions (for patients with bilobar disease)

N (# of pts w/bilobar disease) 18

One session

2(11.1%)

Two sessions

11(61.1%)

Three, etc sessions

5(27.8%)

Irinotecan dose loaded per treatment

Mean = 110.17

median = 100

SD +/- 45

Range = 50-200

Percentage of loaded volume per treatment

≤ 24 percent

2(2%)

25-49

1(1%)

50-74

13(13%)

≥ 75

83(84%)

Irinotecan dose administered per treatment

0-50 mg

15(15%)

51-99 mg

18(20%)

100 mg

50(50%)

150 mg

4(4%)

200 mg

12(12%)

Degree of occlusion achieved per treatment

Complete

24(24%)

Partial

40(40%)

Near

35(35%)